Search Results - "Charpentier, D"

Simultaneous Chiral Resolution of Two Racemic Compounds by Preferential Cocrystallization by Zhou, Fuli, Shemchuk, Oleksii, Charpentier, Maxime D., Matheys, Chloé, Collard, Laurent, ter Horst, Joop H., Leyssens, Tom

“…We tap into an unexplored area of preferential crystallization, being the first to develop simultaneous chiral resolution of two racemic compounds by…”
Get full text

The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLE-onco): a longitudinal multiple case study protocol by Pomey, M P, de Guise, M, Desforges, M, Bouchard, K, Vialaron, C, Normandin, L, Iliescu-Nelea, M, Fortin, I, Ganache, I, Régis, C, Rosberger, Z, Charpentier, D, Bélanger, L, Dorval, M, Ghadiri, D P, Lavoie-Tremblay, M, Boivin, A, Pelletier, J F, Fernandez, N, Danino, A M

“…Quebec is one of the Canadian provinces with the highest rates of cancer incidence and prevalence. A study by the Rossy Cancer Network (RCN) of McGill…”
Get full text

Correction to: The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLEonco): a longitudinal multiple case study protocol by Pomey, M P, de Guise, M, Desforges, M, Bouchard, K, Vialaron, C, Normandin, L, Iliescu-Nelea, M, Fortin, I, Ganache, I, Régis, C, Rosberger, Z, Charpentier, D, Bélanger, L, Dorval, M, Ghadiri, D P, Lavoie-Tremblay, M, Boivin, A, Pelletier, J F, Fernandez, N, Danino, A M

“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text

Prognosis in young women less than 40 years of age with brain metastasis from breast cancer by Mustillo, A, Ayoub, J P, Charpentier, D, Yelle, L, Florescu, M

“…Brain metastasis from breast cancer (bca) in young women is doubly devastating because both quality of life and life expectancy are significantly reduced. With…”
Get full text

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG) by Trudeau, M.E., Crump, M., Charpentier, D., Yelle, L., Bordeleau, L., Matthews, S., Eisenhauer, E.

“…Temozolomide is an oral alkylating agent that crosses the blood–brain barrier, and has preclinical activity in breast cancer. This phase II trial sought to…”
Get full text

Formation of chlorite during thrust fault reactivation. Record of fluid origin and P–T conditions in the Monte Perdido thrust fault (southern Pyrenees) by Lacroix, B., Charpentier, D., Buatier, M., Vennemann, T., Labaume, P., Adatte, T., Travé, A., Dubois, M.

“…The chemical and isotopic compositions of clay minerals such as illite and chlorite are commonly used to quantify diagenetic and low-grade metamorphic…”
Get full text

Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome by Roy, C, Adam, J P, Morin, F, Lemieux-Blanchard, É, Doucet, S, Friedmann, D, Belisle, A, Charpentier, D

“…Pyoderma gangrenosum (pg) is a rare neutrophilic dermatosis characterized by painful necrotic ulceration affecting preferentially the lower extremities…”
Get full text

Conditions and mechanism for the formation of iron-rich Montmorillonite in deep sea sediments (Costa Rica margin): Coupling high resolution mineralogical characterization and geochemical modeling by Charpentier, D., Buatier, M.D., Jacquot, E., Gaudin, A., Wheat, C.G.

“…Iron-rich smectite is commonly described in the diagenetic fraction of deep-sea sediment, as millimeter to centimeter aggregates dispersed in the sediment, or…”
Get full text

Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115 by Maroun, JA, Belanger, K, Seymour, L, Matthews, S, Roach, J, Dionne, J, Soulieres, D, Stewart, D, Goel, R, Charpentier, D, Goss, G, Tomiak, E, Yau, J, Jimeno, J, Chiritescu, G

“…Background: Aplidine is a cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Methods: This phase I study of Aplidine given as a 1-hour…”
Get full text

Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for Praziquantel by Charpentier, Maxime D., Devogelaer, Jan-Joris, Tijink, Arnoud, Meekes, Hugo, Tinnemans, Paul, Vlieg, Elias, de Gelder, René, Johnston, Karen, ter Horst, Joop H.

“…Pharmaceutical cocrystals are highly interesting due to their effect on physicochemical properties and their role in separation technologies, particularly for…”
Get full text

Shale microstructure evolution due to tunnel excavation after 100 years and impact of tectonic paleo-fracturing. Case of Tournemire, France by Charpentier, D., Tessier, D., Cathelineau, M.

“…The mechanical excavation of an underground work results in stress redistribution on the opening, which can induce fracturing. The example of the Toarcian…”
Get full text

Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of Levetiracetam by Charpentier, Maxime D., Venkatramanan, Raghunath, Rougeot, Céline, Leyssens, Tom, Johnston, Karen, ter Horst, Joop H.

“…Chiral molecules are challenging for the pharmaceutical industry because although physical properties of the enantiomers are the same in achiral systems, they…”
Get full text

A Comparison of Simultaneously Integrated Boost using Intensity-modulated Radiation Therapy and Conventional Radiation Therapy in the Setting of Concomitant Carboplatin and 5-Fluorouracil for Locally Advanced Oropharyngeal Carcinoma by Clavel, S, Nguyen, D.H.A, Fortin, B, Després, P, Donath, D, Coulombe, G, Soulières, D, Charpentier, D, Guertin, L, Nguyen-Tan, F

Get full text

Cocrystals of Praziquantel: Discovery by Network-Based Link Prediction by Devogelaer, Jan-Joris, Charpentier, Maxime D, Tijink, Arnoud, Dupray, Valérie, Coquerel, Gérard, Johnston, Karen, Meekes, Hugo, Tinnemans, Paul, Vlieg, Elias, ter Horst, Joop H, de Gelder, René

“…Cocrystallization has been promoted as an attractive early development tool as it can change the physicochemical properties of a target compound and possibly…”
Get full text

Effects of ethylene glycol saturation protocols on XRD patterns; a critical review and discussion by Mosser-Ruck, Régine, Devineau, Karine, Charpentier, Delphine, Cathelineau, Michel

“…Study of the transformation of smectite to illite, chlorite or vermiculite via interstratified clay minerals needs precise qualitative and quantitative…”
Get full text

Life Cycle Greenhouse Gas Emissions of Current Oil Sands Technologies: Surface Mining and In Situ Applications by Bergerson, Joule A, Kofoworola, Oyeshola, Charpentier, Alex D, Sleep, Sylvia, MacLean, Heather L

“…Life cycle greenhouse gas (GHG) emissions associated with two major recovery and extraction processes currently utilized in Alberta’s oil sands, surface mining…”
Get full text

Life Cycle Greenhouse Gas Emissions of Current Oil Sands Technologies: GHOST Model Development and Illustrative Application by Charpentier, Alex D, Kofoworola, Oyeshola, Bergerson, Joule A, MacLean, Heather L

“…A life cycle-based model, GHOST (GreenHouse gas emissions of current Oil Sands Technologies), which quantifies emissions associated with production of diluted…”
Get full text

Understanding the Canadian oil sands industry's greenhouse gas emissions by Charpentier, Alex D, Bergerson, Joule A, MacLean, Heather L

“…The magnitude of Canada’s oil sands reserves, their rapidly expanding and energy intensive production, combined with existing and upcoming greenhouse gas (GHG)…”
Get full text

Is Concurrent Chemotherapy and Radiotherapy in Elderly Head and Neck Patients a Reasonable and Safe Approach? The Notre-Dame Hospital Experience by Mehiri, S, Clavel, S, Fortin, B, Després, P, Coulombe, G, Donath, D, Guertin, L, Soulières, D, Charpentier, D, Nguyen-Tan, P

Get full text

New hydrophobically modified carboxymethylcellulose derivatives by Charpentier, D., Mocanu, G., Carpov, A., Chapelle, S., Merle, L., Müller, G.

“…New hydrophobically substituted carboxymethylcellulose derivatives with different percentages of modification by hexadecylamine (from 0.9 to 6% per monomeric…”
Get full text